Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.22 USD
Change Today +0.002 / 0.94%
Volume 512.0
AMAR On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

amarillo biosciences inc (AMAR) Snapshot

Open
$0.22
Previous Close
$0.21
Day High
$0.22
Day Low
$0.22
52 Week High
12/16/14 - $0.76
52 Week Low
07/9/14 - $0.03
Market Cap
4.3M
Average Volume 10 Days
4.4K
EPS TTM
$0.23
Shares Outstanding
20.1M
EX-Date
--
P/E TM
0.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for AMARILLO BIOSCIENCES INC (AMAR)

Related News

No related news articles were found.

amarillo biosciences inc (AMAR) Related Businessweek News

No Related Businessweek News Found

amarillo biosciences inc (AMAR) Details

Amarillo Biosciences, Inc. engages in the development of biologics for the treatment of human and animal diseases. It owns or licenses four issued patents related to the low-dose oral delivery of interferon; and owns one issued patent on its dietary supplement, Maxisal. The company focuses on research for the treatment of influenza, hepatitis C, thrombocytopenia, and other indications using its natural human interferon alpha technology. Amarillo Biosciences, Inc. was founded in 1984 and is based in Amarillo, Texas.

3 Employees
Last Reported Date: 04/13/15
Founded in 1984

amarillo biosciences inc (AMAR) Top Compensated Officers

Chairman, Chief Executive Officer, Member of ...
Total Annual Compensation: $34.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $40.3K
Compensation as of Fiscal Year 2014.

amarillo biosciences inc (AMAR) Key Developments

Amarillo Biosciences Inc. announced delayed annual 10-K filing

On 03/30/2015, Amarillo Biosciences Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Amarillo Biosciences Inc. will Change its Ticker to AMAR from AMAR.D

Effective January 16, 2015, Amarillo Biosciences Inc. will change its Pink Sheets LLC stock ticker symbol to AMAR from AMAR.D.

Amarillo Biosciences Inc. has Changed its Ticker to AMARD from AMAR.Q

Effective December 16, 2014, Amarillo Biosciences Inc. changed its Pink Sheets LLC stock ticker symbol to AMARD from AMAR.Q.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMAR:US $0.22 USD +0.002

AMAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AMAR.
View Industry Companies
 

Industry Analysis

AMAR

Industry Average

Valuation AMAR Industry Range
Price/Earnings 0.4x
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow 1.5x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMARILLO BIOSCIENCES INC, please visit www.amarbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.